Literature DB >> 22547544

Nocardia brasiliensis induces an immunosuppressive microenvironment that favors chronic infection in BALB/c mice.

Adrian G Rosas-Taraco1, Amira R Perez-Liñan, Paola Bocanegra-Ibarias, Luz I Perez-Rivera, Mario C Salinas-Carmona.   

Abstract

Nocardia brasiliensis is an intracellular microorganism and the most common etiologic agent of actinomycetoma in the Americas. Several intracellular pathogens induce an immunosuppressive microenvironment through increases in CD4+ Foxp3+ regulatory T cells (Treg), thus downregulating other T-cell subpopulations and assuring survival in the host. In this study, we determined whether N. brasiliensis modulates T-lymphocyte responses and their related cytokine profiles in a murine experimental model. We also examined the relationship between N. brasiliensis immunomodulation and pathogenesis and bacterial survival. In early infection, Th17/Tc17 cells were increased at day 3 (P < 0.05) in footpad tissue and spleen. Treg subpopulations peaked at days 7 and 15 (P < 0.01) in the footpad and spleen, respectively. Transforming growth factor β1 (TGF-β1) and interleuki-10 (IL-10) are cytokines known for their immunosuppressive effects. During early and chronic infections, these cytokines were elevated with increased TGF-β1 levels from days 3 to 30 (P < 0.01) and sustained IL-10 expression throughout infection compared to uninfected mice. IL-6 production was increased at day 3 (P < 0.01), whereas gamma interferon (IFN-γ), IL-17A, and IL-23 levels were highest at day 15 postinfection (P < 0.01) when a decrease in the bacterial load (>1 log) was also observed (P < 0.05). After these changes, at 30 to 60 days postinfection, IFN-γ production was decreased, whereas the expression of anti-inflammatory cytokines and the bacterial load again increased (P < 0.05). The increment in Treg cells and the related cytokine profile correlated with reduced inflammation at day 15 (P < 0.05) in the footpad. We conclude that N. brasiliensis modulates the immune system to induce an immunosuppressive microenvironment that benefits its survival during the chronic stage of infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547544      PMCID: PMC3416455          DOI: 10.1128/IAI.06307-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.

Authors:  Magdalena Huber; Sylvia Heink; Henrike Grothe; Anna Guralnik; Katharina Reinhard; Karin Elflein; Thomas Hünig; Hans-Willi Mittrücker; Anne Brüstle; Thomas Kamradt; Michael Lohoff
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

2.  Differential expression of beta 2-integrins and cytokine production between gammadelta and alphabeta T cells in experimental autoimmune encephalomyelitis.

Authors:  Sherry S Smith; Scott R Barnum
Journal:  J Leukoc Biol       Date:  2007-10-10       Impact factor: 4.962

3.  Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity.

Authors:  Tanja Schreiber; Stefan Ehlers; Lisa Heitmann; Alexandra Rausch; Jörg Mages; Peter J Murray; Roland Lang; Christoph Hölscher
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 4.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

5.  Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.

Authors:  Hiromasa Hamada; Maria de la Luz Garcia-Hernandez; Joyce B Reome; Sara K Misra; Tara M Strutt; Kai K McKinstry; Andrea M Cooper; Susan L Swain; Richard W Dutton
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma.

Authors:  Chuanwang Song; Liqiong Luo; Zhang Lei; Bo Li; Zhihui Liang; Guanghui Liu; Dong Li; Guimei Zhang; Bo Huang; Zuo-Hua Feng
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 7.  Cytokine-mediated regulation of antimicrobial proteins.

Authors:  Jay K Kolls; Paul B McCray; Yvonne R Chan
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

8.  Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice.

Authors:  Gillian L Beamer; David K Flaherty; Barnabe D Assogba; Paul Stromberg; Mercedes Gonzalez-Juarrero; Rene de Waal Malefyt; Bridget Vesosky; Joanne Turner
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

9.  IL-17A controls IL-17F production and maintains blood neutrophil counts in mice.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

Review 10.  The roles of IL-17A in inflammatory immune responses and host defense against pathogens.

Authors:  Yoichiro Iwakura; Susumu Nakae; Shinobu Saijo; Harumichi Ishigame
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

View more
  4 in total

1.  Interleukin-17 and matrix metalloprotease-9 expression in the mycetoma granuloma.

Authors:  Emmanuel Edwar Siddig; Ali Mahmoud Mohammed Edris; Sahar Mubarak Bakhiet; Wendy W J van de Sande; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2019-07-11

2.  Nocardia brasiliensis induces formation of foamy macrophages and dendritic cells in vitro and in vivo.

Authors:  Irene Meester; Adrian Geovanni Rosas-Taraco; Mario Cesar Salinas-Carmona
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

3.  Meningitis and Ventriculitis due to Nocardia araoensis Infection.

Authors:  Fumio Yamamoto; Satoshi Yamashita; Hiroyuki Kawano; Tomio Tanigawa; Yosuke Mihara; Toru Gonoi; Yukio Ando
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

4.  Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development.

Authors:  Mario C Salinas-Carmona; Ossian Longoria-Lozano; Humberto R Garza-Esquivel; Juan López-Ulloa; Jorge Reyes-Carrillo; Anna Velia Vázquez-Marmolejo
Journal:  PLoS Negl Trop Dis       Date:  2020-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.